Nutraceutical Supplement in the Management of Hypertension
- Conditions
- Hypertension
- Interventions
- Dietary Supplement: CardiopressinDietary Supplement: Placebo
- Registration Number
- NCT02663479
- Lead Sponsor
- Thorne HealthTech, Inc
- Brief Summary
The purpose of this study is to evaluate the efficacy and safety of a proprietary nutraceutical supplement in capsule form over 4 months in treating blood pressure in a group of chronic hypertensive subjects that are not receiving any pharmaceutical anti-hypertensive agents or other nutraceutical supplements.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Cardiopressin Cardiopressin A 5 capsule proprietary blend of herbal extracts and nutrients Placebo Placebo A 5 capsule placebo matched in color and size to the Experimental supplement
- Primary Outcome Measures
Name Time Method Blood Pressure 4 months Reduction in systolic and diastolic blood pressure as measured by office readings and 24 hour ABM ( ambulatory blood pressure monitor)
- Secondary Outcome Measures
Name Time Method Endothelial Function 4 months Measured via Endopat
Small arterial compliance 4 months Measured via computerized arterial pulse wave analysis (CAPWA)
Large arterial compliance 4 months Measured via computerized arterial pulse wave analysis (CAPWA)
Central arterial blood pressure 4 months Measured via computerized arterial pulse wave analysis (CAPWA)
Trial Locations
- Locations (1)
Hypertension Institute of Nashville, TN
🇺🇸Nashville, Tennessee, United States